Veterinary Hematology Analyzers: What to Compare Before You Buy
Share
A veterinary hematology analyzer should be evaluated as a clinical system—not simply as a machine that produces a CBC. Differential capability, species performance, flagging, smear-review workflow, quality control, reagent use and service all determine whether the result is dependable and useful.
Start with the clinical questions your CBC must answer
List the common cases in which an in-clinic CBC would change or accelerate care: anemia, inflammation, suspected infection, thrombocytopenia, pre-procedure assessment, medication monitoring and urgent presentations. Then identify the species and case mix that generate those questions.
A system that performs well for the majority of canine samples may still be a poor fit if your practice sees substantial feline, equine or exotic volume. Ask for species-specific performance information and understand when the manufacturer directs the user to another method.
Understand what the differential actually provides
Manufacturers use “3-part,” “5-part” and “6-part” terminology differently. The label is less important than the reported cell populations, flags and limitations for each species.
| Comparison point | Questions to ask | Why it matters |
|---|---|---|
| Reported populations | Which leukocyte types are quantified, grouped or only flagged? | Determines the information available for interpretation |
| Species support | What validation and reference intervals apply to canine, feline and other samples? | Performance cannot be assumed across species |
| Flags and graphics | What abnormalities trigger flags, histograms or scattergram review? | Defines when the automated result needs follow-up |
| Platelet assessment | How are clumps, giant platelets and low counts handled? | Automated counts can require manual confirmation |
Ask how abnormal and compromised samples are handled
Normal-sample agreement does not answer every clinical question. During evaluation, include samples spanning the conditions and concentration ranges the practice is likely to encounter. Record flags, reruns, manual-differential requirements and discrepancies with the comparison method.
Preanalytical quality matters as well. Collection technique, anticoagulant ratio, clotting, storage time, temperature and sample mixing can affect results. The analyzer should support a workflow that helps staff recognize unsuitable samples rather than simply producing numbers.
Define the blood-smear review workflow
An automated CBC and a blood smear provide different information. The practice should establish when smear preparation and review are required—for example, analyzer flags, unexpected cytopenias, suspected platelet clumping, abnormal cell populations or results inconsistent with the patient.
Ask whether the vendor provides decision support for flags, morphology training or access to specialist consultation. Avoid language suggesting that an automated differential eliminates professional review.
Evaluate precision, comparison and carryover
Before routine use, the practice should follow an appropriate verification plan based on the instrument, intended use and applicable professional guidance. That may include repeat measurements, comparison with an established method, assessment across relevant concentration ranges and review of carryover or contamination risk.
A 2025 peer-reviewed study demonstrated that comparative programs can be designed to evaluate and harmonize in-clinic hematology analyzers across sites. The practical lesson is that comparison should be structured and documented rather than based on a handful of convenient normal samples.
Build quality control into the operating model
Request the complete quality-control and maintenance protocol before evaluating price. Determine:
- Which control materials are required and how often they are run.
- How control ranges, lot changes and corrective actions are documented.
- Whether calibration is performed by the practice, distributor or manufacturer.
- What daily, weekly and monthly cleaning is required.
- How long reagents remain usable after opening and on the instrument.
- What happens to patient testing when quality control is unacceptable.
The American Society for Veterinary Clinical Pathology provides point-of-care and hematology quality-management guidance that practices can use when building these procedures.
Measure throughput as a workflow
Published tests per hour rarely capture sample preparation, reruns, smear review, cleaning and data entry. During an in-practice trial, record hands-on time and total turnaround during realistic peak periods. Ask whether reagent replacement, startup, shutdown or maintenance interrupts testing.
Connectivity matters too. Confirm how patient identity is entered, how results reach the PIMS, whether reference intervals and units transfer correctly, and what workflow applies if the interface is unavailable.
Calculate the cost per reportable CBC
Include analyzer purchase or financing, diluent, lysing agents, cleaners, controls, calibration materials, maintenance, service, shipping, labor, waste, expired reagents and reruns. Divide the total by reportable results—not samples loaded.
Low-volume practices should pay particular attention to onboard stability, package size and minimum purchases. A low reagent cost per theoretical test can become expensive when partially used containers expire.
Compare service and downtime protection
A hematology analyzer can become clinically important quickly. Ask for support hours, remote diagnostic capability, escalation targets, replacement policy, loaner availability and shipping responsibility in writing. Define the send-out workflow that will protect continuity if the analyzer is unavailable.
A practical evaluation scorecard
- Clinical fit: species, sample types, differential, flags and smear-review rules.
- Result quality: repeatability, comparison findings, abnormal-sample handling and reruns.
- Workflow: sample volume, hands-on time, throughput, maintenance and connectivity.
- Economics: reagent use, controls, waste, labor and cost per reportable result.
- Support: training, escalation, downtime and replacement terms.
Related resources
- How to Evaluate In-Clinic Veterinary Diagnostic Equipment
- Veterinary Diagnostic Equipment Costs: What Quotes Often Leave Out
- Veterinary Diagnostic Equipment: 20 Questions Before You Commit
References
- Flatland B, Freeman KP, Friedrichs KR, et al. Quality management recommendations for automated and semiautomated hematology analyzers in veterinary laboratories. Veterinary Clinical Pathology. 2012.
- Flatland B, et al. ASVCP quality assurance guidelines for point-of-care testing in veterinary medicine. Veterinary Clinical Pathology. 2013.
- American Society for Veterinary Clinical Pathology. Quality Assurance and Laboratory Standard Guidelines.
- Daly S, et al. Comparative Testing of In-Clinic, Point-of-Care Hematology Analyzers. 2025.